NURO Rasio cepet NeuroMetrix, Inc.

NeuroMetrix, Inc. (NURO) develops innovative Quell wearable gadgets to combat chronic pain without the use of medication. The current liquidity ratio stands at 14.07, while this price chart reflects the impact of sales of neurostimulation systems and diagnostic devices. The company is focusing on expanding B2B supplies of bioelectronic devices to clinics, aiming to increase its presence in the high-tech medical equipment segment.

NeuroMetrix, Inc. (NURO) is actively integrating Quell bioelectronic systems into clinical practice, expanding its B2B market segment. This liquidity ratio, excluding illiquid assets, assesses the company's ability to meet short-term obligations using cash and accounts receivable while ignoring inventory. Analyzing this metric determines the business's actual solvency amid market volatility. The stability of this trend confirms the issuer's financial viability and supports the resilience of its share price.